Selenoproteins as Prognostic Markers and Therapeutic Targets in Breast Cancer.
Recruiting · NCT05817227 · Observational (researchers observe without assigning treatment)
View the official record on ClinicalTrials.gov →What this trial is about
This is multicentric, spontaneous, observational, retrospective and prospective study.
Who can take part
Age range
18 Years and older
Sex
Female
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- TNBC breast cancer patients, before any drug treatment
- healthy women aged 25-60
Exclusion criteria
- donors suffering from diabetes, hypertension, active infectious states, HIV infection, Hepatitis B or C, chronic inflammatory diseases, current or previous neoplasms, heart disease or drug treatment.
Where it is running
2 locations listed.
- Istituto Nazionale Tumori - Fondazione "G.Pascale", IRCCS - Naples, Napoli, Italy
- Istituto Nazionale Tumori Regina Elena - Roma, Roma, Italy